All In Biotech

Drug Trial Radar · NCT02753530

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)

Last checked: Nov 19, 2026Latest source record: May 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

152

Actual

Start

Aug 16, 2017

Primary completion

Jan 11, 2021

Study completion Jan 11, 2021

Sponsor

Lead sponsor
ZevraDenmarkIndustry
Sponsor type
Industry
Collaborators
University of Kansas Medical Center; University College, London
First posted
Apr 28, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Funding Source - FDA Office of Orphan Products Development (OOPD). The purpose of this study is to evaluate the safety and efficacy of the study drug, arimoclomol in IBM patients.

Conditions

  • Inclusion Body Myositis

Interventions

  • ArimoclomolDrug

    2 capsules (2 x 124 mg arimoclomol base; equivalent to 2 x 200 mg arimoclomol citrate) taken 3 times daily during breakfast, early afternoon, and at bedtime

  • PlaceboOther

    2 matched placebo capsules taken 3 times daily during breakfast, early afternoon, and at bedtime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Inclusion Body Myositis Functional Rating Scale (IBMFRS) Total ScoreTime frame: Change from Baseline to Month 20

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Phoenix Neurological Associates

    Phoenix, Arizona

  • University of California, Irvine

    Irvine, California

  • University of Colorado School of Medicine

    Aurora, Colorado

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Johns Hopkins University

    Baltimore, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • University of Rochester

    Rochester, New York

  • The Ohio State University

    Columbus, Ohio

  • Nerve and Muscle Center of Texas

    Houston, Texas

  • University of Utah

    Salt Lake City, Utah

  • University of Virginia

    Charlottesville, Virginia

  • University College of London

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.